Search All UT System Experts

Discontinuation rates of warfarin versus direct acting oral anticoagulants in US clinical practice: Results from Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II (ORBIT-AF II): Discontinuation Rates of Warfarin vs DOACs

Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II

Research output: Contribution to journal › Article › peer-review

13 Scopus citations

Fingerprint

Dive into the research topics of 'Discontinuation rates of warfarin versus direct acting oral anticoagulants in US clinical practice: Results from Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II (ORBIT-AF II): Discontinuation Rates of Warfarin vs DOACs'. Together they form a unique fingerprint.

Medicine & Life Sciences